The Down-regulation of Notch1 Inhibits the Invasion and Migration of Hepatocellular Carcinoma Cells by Inactivating the Cyclooxygenase-2/Snail/E-cadherin Pathway in Vitro
Overview
Affiliations
Background: The Notch signaling pathway plays an important role in cancer, but the mechanism by which Notch1 participates in invasion and migration of hepatocellular carcinoma (HCC) cells is unclear.
Aims: Our purpose is to confirm the anti-invasion and anti-migration effects of the down-regulation of Notch1 in HCC cells.
Methods: The invasion and migration capacities of HCC cells were detected with Transwell cell culture chambers. The expressions of Notch1, Notch1 intracellular domain (N1ICD), E-cadherin, Snail, and cyclooxygenase-2 (COX-2) were analyzed by RT-PCR and/or western blotting. Notch1 and Snail were down-regulated by RNA interference, and COX-2 was inhibited by NS-398. Cell apoptosis was analyzed by MTT and flow cytometry.
Results: In HCC cells, Snail, Notch1, and COX-2 were up-regulated, and E-cadherin was down-regulated in mRNA and/or protein levels. The down-regulation of Snail or Notch1 or the inhibition of COX-2, respectively, can increase the mRNA and protein expressions of E-cadherin and decrease the invasion and migration capabilities of HCC cell. Down-regulated Notch1 or inhibited COX-2 can reduce the mRNA and protein expressions of Snail. The down-regulation of Notch1 can also reduce the protein expression of COX-2. However, exogenous PGE2 can reverse the role of down-regulated Notch1. The results of MTT and flow cytometry showed that down-regulated Notch1 did not affect HCC cell viability.
Conclusions: Down-regulated Notch1 may be an effective approach to inactivating Snail/E-cadherin by regulating COX-2, which results in inhibiting the invasion and migration of HCC cells. The inhibitory effects of down-regulated Notch1 on cell invasion and migration were independent of apoptosis.
Pan-cancer analysis of FBXW family with potential implications in prognosis and immune infiltration.
Huang T, Ouyang X, Li J, Shi B, Shan Z, Shi Z Front Immunol. 2023; 13:1084339.
PMID: 36591289 PMC: 9795248. DOI: 10.3389/fimmu.2022.1084339.
Mechanistic Insights into the Pharmacological Significance of Silymarin.
Wadhwa K, Pahwa R, Kumar M, Kumar S, Chander Sharma P, Singh G Molecules. 2022; 27(16).
PMID: 36014565 PMC: 9414257. DOI: 10.3390/molecules27165327.
Molecular mechanism of albumin in suppressing invasion and metastasis of hepatocellular carcinoma.
Fu X, Yang Y, Zhang D Liver Int. 2021; 42(3):696-709.
PMID: 34854209 PMC: 9299813. DOI: 10.1111/liv.15115.
Novel Tyrosine Kinase Targets in Urothelial Carcinoma.
Torres-Jimenez J, Albarran-Fernandez V, Pozas J, Roman-Gil M, Esteban-Villarrubia J, Carrato A Int J Mol Sci. 2021; 22(2).
PMID: 33451055 PMC: 7828553. DOI: 10.3390/ijms22020747.
Tai Y, Zhang L, Gao J, Zhao C, Tong H, Ye C Cancer Manag Res. 2019; 11:2831-2848.
PMID: 31114336 PMC: 6497485. DOI: 10.2147/CMAR.S183376.